Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease
Although only a small fraction will ever develop the active form of tuberculosis (ATB) disease, chemoprophylaxis treatment in latent TB infected (LTBI) individuals is an effective strategy to control pathogen transmission. Characterizing immune responses in LTBI upon chemoprophylactic treatment is i...
Hoofdauteurs: | Burel, JG, Singhania, A, Dubelko, P, Muller, J, Tanner, R, Parizotto, E, Dedicoat, M, Fletcher, TE, Dunbar, J, Cunningham, AF, Lindestam Arlehamn, CS, Catanzaro, DG, Catanzaro, A, Rodwell, T, McShane, H, O'Shea, MK, Peters, B |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
Elsevier
2021
|
Gelijkaardige items
-
Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants
door: O'Shea, M, et al.
Gepubliceerd in: (2014) -
Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
door: Matthew K O'Shea, et al.
Gepubliceerd in: (2014-01-01) -
Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
door: O'Shea, M, et al.
Gepubliceerd in: (2018) -
In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
door: Mcshane, H, et al.
Gepubliceerd in: (2017) -
Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review.
door: Elisea Avalos, et al.
Gepubliceerd in: (2015-01-01)